2005
DOI: 10.1080/07853890510037374
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary fungal infection with yeasts andpneumocystisin patients with hematological malignancy

Abstract: Invasive fungal infections are an important cause of morbidity and mortality in patients with hematological malignancies, and in particular fungal pneumonia is the main clinical manifestation in this category of patients. The fungal agents responsible for this complication are various, but Aspergillus spp. and other molds such as Zygomycetes or Fusarium spp. represent the most frequently isolated micro-organisms. Less commonly, pneumonia could be due to other 'no-molds' fungal agents such as Candida spp, Crypt… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2007
2007
2020
2020

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(6 citation statements)
references
References 63 publications
0
5
0
Order By: Relevance
“…The most serious clinical manifestation of cryptococcal infection is meningoencephalitis, which is occasionally associated with cryptococcemia and is a predictor of poor outcome (2,3). Cryptococcal pneumonia is also serious, but it is associated with a better prognosis and is more prevalent in organ transplant and hematologic malignancy patients (4)(5)(6). More recently, an immune reconstitution syndrome has been described both in AIDS patients with the availability of antiretroviral therapy (7) and in organ transplant/hematologic malignancy patients (8).…”
Section: Introductionmentioning
confidence: 99%
“…The most serious clinical manifestation of cryptococcal infection is meningoencephalitis, which is occasionally associated with cryptococcemia and is a predictor of poor outcome (2,3). Cryptococcal pneumonia is also serious, but it is associated with a better prognosis and is more prevalent in organ transplant and hematologic malignancy patients (4)(5)(6). More recently, an immune reconstitution syndrome has been described both in AIDS patients with the availability of antiretroviral therapy (7) and in organ transplant/hematologic malignancy patients (8).…”
Section: Introductionmentioning
confidence: 99%
“…Fungi which affect immunosuppressed individuals are frequently species of Aspergillus, Candida, Cryptococcus, geographically restricted agents, and newly emerging fungal pathogens. 7,8 In one study, Aspergillus spp. was isolated from 33% (86/251 cases) of lung-transplantation recipients, which involved colonization (n = 50), tracheobronchial lesions (n = 17) or invasive aspergillosis (n = 19).…”
Section: Introductionmentioning
confidence: 99%
“…PCP has emerged as a concern since the epidemic of acquired immune deficiency syndrome (AIDS) in the 1980s and thus has been comprehensively studied in HIV-positive population [1]. However, since the early 2000s, more and more PCPs have been diagnosed among HIV-negative patients as the use of immunosuppressive agents increases in treating malignancies, autoimmune disorders, and inflammatory diseases, as well as in solid organ transplants [2][3][4]. In contrast to HIV-positive PCP, where the mortality has been reduced to less than 20%, PCP in HIV-negative patients has a poor prognosis with mortality rates of 30-55% as previously reported [5,6].…”
Section: Introductionmentioning
confidence: 99%